In fact, budlein A ameliorates murine antigen-induced arthritis by inhibiting NF-κB activation and thereby Il-33, Tnf-α, Il-1β, endothelin-1, and Cox-2 mRNA expression in the knee joint (Zarpelon et al., 2017). The gene discussed is IL33; the disease is arthritic joint disease.